Human recombinant anti-thyroperoxidase autoantibodies: In vitro cytotoxic activity on papillary thyroid cancer expressing TPO

British Journal of Cancer

Volumn 102, Issue 5, 2010, Pages 852-861

  Rebuffat, S A ^a   Morin, M ^a,c   Nguyen, B ^a   Castex, F ^a   Robert, B ^b   Peraldi Roux S ^a  

^a EA7288   (France)

^b INSERM   (France)

^c INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

Author keywords

Anti TPO antibodies; Cytotoxicity; Immunotherapy; Thyroid cancer

Indexed keywords

AUTOANTIBODY; CD32 ANTIGEN; CD64 ANTIGEN; FC RECEPTOR; RECOMBINANT ANTIBODY; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; THYROID PEROXIDASE; THYROPEROXIDASE ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CANCER CELL CULTURE; CELL PROLIFERATION; CHO CELL; COMPLEMENT DEPENDENT CYTOTOXICITY; CONTROLLED STUDY; EFFECTOR CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INSECT CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; THYROID PAPILLARY CARCINOMA;

ANIMALS; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; AUTOANTIBODIES; AUTOANTIGENS; CARCINOMA, PAPILLARY; CELL PROLIFERATION; CHO CELLS; COMPLEMENT C1Q; CRICETINAE; CRICETULUS; HUMANS; IMMUNOGLOBULIN G; IODIDE PEROXIDASE; IRON-BINDING PROTEINS; THYROID NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 77649270903     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605464     Document Type: Article

References (38)

1. Alvarez-Rueda N, Leprieur S, Clemenceau B, Supiot S, Sebille-Rivain V, Faivre-Chauvet A, Davodeau F, Paris F, Barbet J, Aubry J, Birklé S (2007) Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen. Clin Cancer Res 13: 5613s-5620s
2. Bjorge L, Hakulinen J, Wahlstrom T, Matre R, Meri S (1997) Complement-regulatory proteins in ovarian malignancies. Int J Cancer 70: 14-25
3. Bogner U, Gruters A, Sigle B, Helge H, Schleusener H (1989) Cytotoxic antibodies in congenital hypothyroidism. J Clin Endocrinol Metab 68: 671-675
4. Brasoveanu LI, Altomonte M, Fonsatti E, Colizzi F, Coral S, Nicotra MR, Cattarossi I, Cattelan A, Natali PG, Maio M (1996) Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells. Lab Invest 74: 33-42
5. Bresson D, Rebuffat SA, Nguyen B, Banga JP, Gardas A, Peraldi-Roux S (2005) New insights into the conformational dominant epitopes on thyroid peroxidase recognized by human autoantibodies. Endocrinology 146: 2834-2844
6. Bresson D, Chardes T, Chapal N, Bes C, Cerutti M, Devauchelle G, Bouanani M, Mani JC, Peraldi-Roux S (2001) Pertinence of kappa and lambda recombinant antibodies directed against thyroid peroxidase in thyroid autoimmune disease. Hum Antibodies 10: 109-118
7. Bresson D, Cerutti M, Devauchelle G, Pugniere M, Roquet F, Bes C, Bossard C, Chardes T, Peraldi-Roux S (2003) Localization of the discontinuous immunodominant region recognized by human anti-thyroperoxidase autoantibodies in autoimmune thyroid diseases. J Biol Chem 278: 9560-9569
8. Bresson D, Pugniere M, Roquet F, Rebuffat SA, N-Guyen B, Cerutti M, Guo J, McLachlan SM, Rapoport B, Estienne V, Ruf J, Chardès T, Péraldi-Roux S (2004) Directed mutagenesis in region 713-720 of human thyroperoxidase assigns 713KFPED717 residues as being involved in the B domain of the discontinuous immunodominant region recognized by human autoantibodies. J Biol Chem 279: 39058-39067
9. Chapal N, Chardes T, Bresson D, Pugniere M, Mani JC, Pau B, Bouanani M, Peraldi-Roux S (2001) Thyroid peroxidase autoantibodies obtained from random single chain FV libraries contain the same heavy/light chain combinations as occur in vivo. Endocrinology 142: 4740-4750
10. Chapal N, Peraldi-Roux S, Bresson D, Pugniere M, Mani JC, Granier C, Baldet L, Guerrier B, Pau B, Bouanani M (2000) Human anti-thyroid peroxidase single-chain fragment variable of Ig isolated from a combinatorial library assembled in-cell: insights into the in vivo situation. J Immunol 164: 4162-4169
11. Chiovato L, Bassi P, Santini F, Mammoli C, Lapi P, Carayon P, Pinchera A (1993) Antibodies producing complement-mediated thyroid cytotoxicity in patients with atrophic or goitrous autoimmune thyroiditis. J Clin Endocrinol Metab 77: 1700-1705
12. Czarnocka B, Ruf J, Ferrand M, Carayon P, Lissitzky S (1985) Purification of the human thyroid peroxidase and its identification as the microsomal antigen involved in autoimmune thyroid diseases. FEBS Lett 190: 147-152
13. Czarnocka B, Pastuszko D, Janota-Bzowski M, Weetman AP, Watson PF, Kemp EH, McIntosh RS, Asghar MS, Jarzab B, Gubala E, Wloch J, Lange D (2001) Is there loss or qualitative changes in the expression of thyroid peroxidase protein in thyroid epithelial cancer? Br J Cancer 85: 875-880
14. Estour B, Van Herle AJ, Juillard GJ, Totanes TL, Sparkes RS, Giuliano AE, Klandorf H (1989) Characterization of a human follicular thyroid carcinoma cell line (UCLA RO 82 W-1). Virchows Arch B Cell Pathol Incl Mol Pathol 57: 167-174
15. Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang SH, Koeffler HP (1993) High prevalence of mutations of the p53 gene in poorly differentiated human thyroid carcinomas. J Clin Invest 91: 179-184
16. Garcia S, Vassko V, Henry JF, De Micco C (1998) Comparison of thyroid peroxidase expression with cellular proliferation in thyroid follicular tumors. Thyroid 8: 745-749
17. Gorter A, Blok VT, Haasnoot WH, Ensink NG, Daha MR, Fleuren GJ (1996) Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis. Lab Invest 74: 1039-1049
18. Guo J, Jaume JC, Rapoport B, McLachlan SM (1997) Recombinant thyroid peroxidase-specific Fab converted to immunoglobulin G (IgG) molecules: evidence for thyroid cell damage by IgG1, but not IgG4, autoantibodies. J Clin Endocrinol Metab 82: 925-931
19. Jefferis R, Lund J, Pound JD (1998) IgG-Fc-mediated effector functions: molecular definition of interaction sites for effector ligands and the role of glycosylation. Immunol Rev 163: 59-76
20. Lifely MR, Hale C, Boyce S, Keen MJ, Phillips J (1995) Glycosylation and biological activity of CAMPATH-1H expressed in different cell lines and grown under different culture conditions. Glycobiology 5: 813-822
21. Mark J, Ekedahl C, Dahlenfors R, Westermark B (1987) Cytogenetical observations in five human anaplastic thyroid carcinomas. Hereditas 107: 163-174
22. McLachlan SM, Rapoport B (1992) The molecular biology of thyroid peroxidase: cloning, expression and role as autoantigen in autoimmune thyroid disease. Endocr Rev 13: 192-206
23. McLachlan SM, Rapoport B (2000) Autoimmune response to the thyroid in humans: thyroid peroxidase-the common autoantigenic denominator. Int Rev Immunol 19: 587-618
24. Metcalfe RA, Oh YS, Stroud C, Arnold K, Weetman AP (1997) Analysis of antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease. Autoimmunity 25: 65-72
25. Ortaldo JR, Woodhouse C, Morgan AC, Herberman RB, Cheresh DA, Reisfeld R (1987) Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies. J Immunol 138: 3566-3572
26. Parkes AB, Othman S, Hall R, John R, Richards CJ, Lazarus JH (1994) The role of complement in the pathogenesis of postpartum thyroiditis. J Clin Endocrinol Metab 79: 395-400
27. Peltz GA, Trounstine ML, Moore KW (1988) Cloned and expressed human Fc receptor for IgG mediates anti-CD3-dependent lymphoproliferation. J Immunol 141: 1891-1896
28. Rebuffat SA, Bresson D, Nguyen B, Peraldi-Roux S (2006) The key residues in the immunodominant region 353-363 of human thyroid peroxidase were identified. Int Immunol 18: 1091-1099
29. Rebuffat SA, Nguyen B, Robert B, Castex F, Peraldi-Roux S (2008) Antithyroperoxidase antibody-dependent cytotoxicity in autoimmune thyroid disease. J Clin Endocrinol Metab 93: 929-934
30. Rodien P, Madec AM, Ruf J, Rajas F, Bornet H, Carayon P, Orgiazzi J (1996) Antibody-dependent cell-mediated cytotoxicity in autoimmune thyroid disease: relationship to antithyroperoxidase antibodies. J Clin Endocrinol Metab 81: 2595-2600
31. Ruf J, Toubert ME, Czarnocka B, Durand-Gorde JM, Ferrand M, Carayon P (1989) Relationship between immunological structure and biochemical properties of human thyroid peroxidase. Endocrinology 125: 1211-1218
32. Schonberger J, Bauer J, Spruss T, Weber G, Chahoud I, Eilles C, Grimm D (2000) Establishment and characterization of the follicular thyroid carcinoma cell line ML-1. J Mol Med 78: 102-110
33. Steplewski Z (1993) Advances and outlooks for immunotherapy of cancer. Hybridoma 12: 493-500
34. Tao MH, Morrison SL (1989) Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J Immunol 143: 2595-2601
35. van Vugt MJ, Kleijmeer MJ, Keler T, Zeelenberg I, van Dijk MA, Leusen JH, Geuze HJ, van de Winkel JG (1999) The FcgammaRIa (CD64) ligand binding chain triggers major histocompatibility complex class II antigen presentation independently of its associated FcR gamma-chain. Blood 94: 808-817
36. Vivier E, Rochet N, Ackerly M, Petrini J, Levine H, Daley J, Anderson P (1992) Signaling function of reconstituted CD16:zeta:gamma receptor complex isoforms. Int Immunol 4: 1313-1323
37. Wadeleux P, Winand-Devigne J, Ruf J, Carayon P, Winand R (1989) Cytotoxic assay of circulating thyroid peroxidase antibodies. Auto-immunity 4: 247-254
38. Wright A, Morrison SL (1997) Effect of glycosylation on antibody function: implications for genetic engineering. Trends Biotechnol 15: 26-32